S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom

Verastem (VSTM) Earnings Date, Estimates & Call Transcripts

$10.84
-0.09 (-0.82%)
(As of 04/17/2024 ET)

Earnings Summary

Upcoming
Earnings Date
May. 14Estimated
Actual EPS
(Mar. 14)
-$1.02 Missed By -$0.20
Consensus EPS
(Mar. 14)
-$0.82
Skip Charts & View Estimated and Actual Earnings Data

VSTM Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

VSTM Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Verastem Analyst EPS Estimates

Current Year EPS Consensus Estimate:($4.31) EPS
Next Year EPS Consensus Estimate: ($2.84) EPS

VSTM Earnings Date and Information

Verastem last released its earnings data on March 14th, 2024. The biopharmaceutical company reported ($1.02) earnings per share for the quarter, missing the consensus estimate of ($0.82) by $0.20. Verastem has generated ($4.10) earnings per share over the last year (($4.10) diluted earnings per share). Earnings for Verastem are expected to grow in the coming year, from ($4.31) to ($2.84) per share. Verastem has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off prior year's report dates.

Verastem Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/14/2024
Estimated)
------- 
3/14/2024Q4 2023($0.82)($1.02)($0.20)($1.02)--
11/8/2023Q3 2023($0.92)($0.75)+$0.17($0.75)--
8/8/2023Q2 2023($1.13)($1.37)($0.24)($1.37)--
5/9/2023Q1 2023($1.08)($0.96)+$0.12($0.96)--
3/14/2023Q4 2022-($0.96)($0.96)($0.08)--
11/3/2022Q3 2022($1.44)($1.08)+$0.36($0.09)--
8/8/2022Q2 2022($1.32)($1.44)($0.12)($0.12)--
5/9/2022Q1 2022($0.96)($1.08)($0.12)($0.09)$2.50 million$2.60 million
3/28/2022Q4 2021($0.96)($1.08)($0.12)($0.09)-$0.55 million
11/4/2021Q3 2021($0.96)($1.56)($0.60)($0.13)--
8/1/2021Q2 2021($0.96)($1.20)($0.24)($0.10)-$0.50 million
5/11/2021Q1 2021($1.08)($1.08)-($0.09)-$1.01 million

Verastem Earnings - Frequently Asked Questions

When is Verastem's earnings date?

Verastem has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off last year's report dates. Learn more on VSTM's earnings history.

Did Verastem beat their earnings estimates last quarter?

In the previous quarter, Verastem (NASDAQ:VSTM) missed the analysts' consensus estimate of ($0.82) by $0.20 with a reported earnings per share (EPS) of ($1.02). Learn more on analysts' earnings estimate vs. VSTM's actual earnings.

How much revenue does Verastem generate each year?

Verastem (NASDAQ:VSTM) has a recorded annual revenue of $2.60 million.

How much profit does Verastem generate each year?

Verastem (NASDAQ:VSTM) has a recorded net income of -$87.37 million. VSTM has generated -$4.10 earnings per share over the last four quarters.

What is Verastem's EPS forecast for next year?

Verastem's earnings are expected to grow from ($4.31) per share to ($2.84) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:VSTM) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners